Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1 By Ogkologos - July 1, 2025 596 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KOMET study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Camizestrant ESMO Calls for the Ring-Fenced Funding of Health Under the 2028-2034 Long-Term Budget of the EU, the Multiannual Financial Framework (MFF) New ESMO President 2029-2030 Elected MOST POPULAR News digest – skin cancer deaths, Public Health England plans and... August 22, 2020 As Rates of Some Cancers Increase in Younger People, Researchers Search... May 14, 2025 Tovorafenib Approved for Some Children with Low-Grade Glioma May 28, 2024 Artificial Intelligence Brings Pancreatic Cancer Screening One Step Closer to Reality... July 2, 2020 Load more HOT NEWS Biopsia por aspiración con aguja fina (PAAF): Cómo prepararse y qué... Study Identifies a Potential Cause of Immunotherapy’s Heart-Related Side Effects FDA Approves Imlunestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast... Intratumoural and Intracavitary Administration of Ipilimumab Plus Nivolumab Is Feasible and...
